For the first time, our research uses the TCGA project to investigate a pan-cancer analysis of CCNA2, including gene expression, clinical survival prognosis, pathological stage, immune cell infiltration, immune cell markers, and immune checkpoints. The gene discussed is CCNA2; the disease is cancer.